Epic Ventures Gains $200M Fresh Capital
August 28, 2025
Epic Ventures has received $200M of fresh capital to support early-stage founders solving meaningful problems in healthcare, software, AI, and beyond. The fund is positioned as a strategic public and private initiative to back the region’s best entrepreneurs and attract collaboration between the top innovators in the world and the principal economic centers of the Intermountain West. The company will be investing locally and globally.
Recent News
- Collaboration with Quest Diagnostics to expand kidneyintelX.dkd TM testing in the United States
- Utah Business Innovation Awards Summit Recap
- Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
- Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
